SSAT SSAT
 
 
Abstracts Only
SSAT residents Corner
Find SSAT on Facebook SSAT YouTube Channel Follow SSAT on Twitter
SSAT
 

Back to 2011 Program


Assessment of Quality of Life Following Total Pancreatectomy and Islet Cells Autotransplant for Chronic Pancreatitis
Juan R Aguilar-Saavedra*, Greg Lentz, Judith Scheman, Tyler Stevens, Matthew Walsh
Surgery, Cleveland Clinic, Cleveland, OH

Background: The primary goal in TP-IAT is to improve QOL by alleviating pain and discontinue narcotics while preventing or minimizing surgical diabetes. QOL outcomes following any surgery for CP are lacking. Objective: Review the results of TP-AIT by assessing QOL and beta cell function. Methods: A retrospective review of a prospective database for TP-IAT from November 2007 through October 2010. A standardized pre and post-operative using the Depression Anxiety Stress Scale (DASS) and the Pain Disability Index (PDI). A visual analogue pain scale was used to asses global pain. Diabetes assessment by measuring Hb 1Ac pre and post surgery, and C-Peptide postoperative. Results: There were 20 patients who underwent TP-AITD. The median age was 42 years old (17-73) and 8 (40%) were women. CP etiology was: idiopathic in 10(50%), familiar in 5, alcohol in 4, autoimmune and gallstones in 1 each. Prior pancreatic resection was performed in 2(10%) patients. The median islet cell equivalents infused was 299,508. There was no mortality. Complications were present in 8(40%): bleeding in 4(20%) due to anticoagulation 2 of theses required a reoperation; gastroparesia in 3(15%). Median LOS was 12 days. The median follow-up was 16 months. The mean pre HbA1c was 6.03 and post Hb A1c was 7.72. The median post-op C-peptide levels were 0.78. Dose of Novolog were 12U (4-25) per day, Lantus 9.71U (5-20) per day, Humolog 7.5U (2-30).The QOL data are summarize in the table 1.The patients graded their abdominal pain pre and postoperative are as follows: none to mild in [0(0%)vs15(76%)], moderate in [9(45%)vs3(14%)] and severe in [11(55%)vs2(10%)].The DASS was completed pre and post operative: Depression was categorized as follows: mild in [3(14%)vs2(10%)], moderate in [3(14%)vs1(4%)], severe [4(19%)vs0], extremely-severe [3(14%)vs2(10%)] (p=0.012). Anxiety was categorized as mild in [2(10%)vs1(4%)], moderate in [4(19%)vs1(4%)], severe in [1(4%)vs1(4%)], extremely-severe [4(19%)vs2(10%)] (p=0.062). PDI was completed both pre and post operative: 1. Family/home responsibilities: Severe in [12(61%)vs2(10%)]. 2. Recreation: Severe in [16(80%)vs4(20%)]. 3. Social Activity: Severe in [13(66%)vs3(15%)]. 4.Ocupation: Severe in[14(70%)vs3(20%)]. 5.Sexual Behavior: Severe in [11(55%)vs2(10%)]. 6.Self care: Severe in [6(30%)vs0(0%)] patients. 7.Life support activities: Severe in [9(45%)vs1(10%)]. Alcohol and drug abuse was diagnosed in 3 patients post-operative. Passive suicidal ideation was present in 2 patients.Conclusions: These preliminary results show that TP-AIT significantly improves pain, depression, anxiety and QOL measures in appropriately selected patients with CP.
Table 1 PreOp PostOp p Value
PDI
Family Home responsabilities
Severe 12(61%) 2(10%)
Recreation
Severe 16(80%) 4 (20%)
Social Activity
Severe 13 (66%) 3 (15%)
Ocupation
Severe 14 (70%) 3 (20%)
Sexual Behavior
Severe 11 (55%) 2 (10%)
Self care
Severe 6 (30%) 0%
Life support activity
Severe 9 (45%) 1 (10%)
DASS
Depression p=0.012
Severe 4 (19%) 0%
Anxiety p=0.062
Severe 1 (4%) 1 (4%)
Pain Scale
Severe 11 (55%) 2 (10%)


Back to 2011 Program

 

 
Home | Contact SSAT